Abstract
Considering the beneficial and non-invasive effects of laser as a therapy, the possibility of using it in cancer patients would be of great interest to the clinical area. However, the available literature is still scarce for the definition of the ideal dosimetric parameters of photobiomodulation (FBM) in cancer cells, and when considering the use of the therapy as a bioinhibitory treatment in this cell type, more studies are needed to elucidate the main factors responsible for the different behaviors in these cells, since in specific parameters this therapy can promote biostimulation or even cell inhibition, It should be used with caution in clinical practice, avoiding increasing existing cancerous tissue.
DOI:https://doi.org/10.56238/sevened2024.028-015